loadpatents
name:-0.25602912902832
name:-0.022851943969727
name:-0.00061511993408203
Kataoka; Shiro Patent Filings

Kataoka; Shiro

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kataoka; Shiro.The latest application filed is for "bifidobacterium spp. expressing and secreting diabody-type bsab".

Company Profile
0.14.16
  • Kataoka; Shiro - Nagano JP
  • Kataoka; Shiro - Tokyo JP
  • Kataoka; Shiro - Tokyo-to JP
  • Kataoka; Shiro - Shibuya-ku JP
  • Kataoka; Shiro - Chiyodu-ku JP
  • Kataoka; Shiro - Takasaki JP
  • KATAOKA; Shiro - Takasaki-shi JP
  • Kataoka; Shiro - Gunma JP
  • Kataoka; Shiro - Nagoya JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Bifidobacterium Spp. Expressing And Secreting Diabody-type Bsab
App 20220281998 - Shimatani; Yuko ;   et al.
2022-09-08
Anti-CD98 antibody processes
Grant 9,688,770 - Tahara , et al. June 27, 2
2017-06-27
Anti-cd98 Antibody Processes
App 20150307621 - TAHARA; Tomoyuki ;   et al.
2015-10-29
Anti-CD98 antibody processes
Grant 9,051,374 - Tahara , et al. June 9, 2
2015-06-09
Agonist antibody to human thrombopoietin receptor
Grant 8,999,329 - Kai , et al. April 7, 2
2015-04-07
Anti-cd98 Antibody Processes
App 20140037636 - TAHARA; Tomoyuki ;   et al.
2014-02-06
Anti-CD98 antibody
Grant 8,486,402 - Tahara , et al. July 16, 2
2013-07-16
Agonist Antibody To Human Thrombopoietin Receptor
App 20130053547 - KAI; Masayuki ;   et al.
2013-02-28
Agonist antibody to human thrombopoietin receptor
Grant 8,236,314 - Kai , et al. August 7, 2
2012-08-07
Agonist Antibody To Human Thrombopoietin Receptor
App 20120053326 - KAI; Masayuki ;   et al.
2012-03-01
Anti-cd98 Antibody
App 20110280884 - TAHARA; Tomoyuki ;   et al.
2011-11-17
Agonist antibody to human thrombopoietin receptor
Grant 8,048,421 - Kai , et al. November 1, 2
2011-11-01
Anti-CD98 antibody
Grant 7,943,745 - Tahara , et al. May 17, 2
2011-05-17
Novel Anti-cd98 Antibody
App 20100143367 - Tahara; Tomoyuki ;   et al.
2010-06-10
Agonist Antibody To Human Thrombopoietin Receptor
App 20100004429 - Kai; Masayuki ;   et al.
2010-01-07
Anti-a33 Antibody
App 20090299039 - Kataoka; Shiro ;   et al.
2009-12-03
Anti-A33 antibody
Grant 7,579,187 - Kataoka , et al. August 25, 2
2009-08-25
Anti-A33 antibody
Grant 7,432,359 - Kataoka , et al. October 7, 2
2008-10-07
Anti-a33 Antibody
App 20080200654 - KATAOKA; Shiro ;   et al.
2008-08-21
Anti-HLA-DR antibody
Grant 7,262,278 - Tawara , et al. August 28, 2
2007-08-28
Anti-a33 antibody
App 20070141054 - Kataoka; Shiro ;   et al.
2007-06-21
Endothelial cell specific antibodies and uses thereof
App 20070020271 - Teicher; Beverly ;   et al.
2007-01-25
Anti-TRAIL-R antibodies
Grant 7,115,717 - Mori , et al. October 3, 2
2006-10-03
Anti-TRAIL-R antibody
App 20050249729 - Mori, Eiji ;   et al.
2005-11-10
Anti-trail-r antibodies
App 20040214235 - Mori, Eiji ;   et al.
2004-10-28
Anti-hla-dr antibody
App 20040091974 - Tawara, Tomonori ;   et al.
2004-05-13
Process for producing polyamide blow molded product
Grant 5,846,478 - Onishi , et al. December 8, 1
1998-12-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed